
New test identifies high-risk childhood brain tumours, improving treatment decisions
Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma – the most common type of malignant brain tumour in children – and potentially sparing young patients from unnecessary treatments and their harmful long-term side effects.